ICD-10 Coding for Acute Myeloid Leukemia(C92.00, C92.01)
Complete ICD-10-CM coding and documentation guide for Acute Myeloid Leukemia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Acute Myeloid Leukemia
C92.0-C92.9Primary Range
Acute myeloid leukemia and related conditions
This range covers all forms of acute myeloid leukemia, including those in remission or relapse.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C92.00 | Acute myeloid leukemia, not having achieved remission | Use when AML is newly diagnosed or relapsed without achieving remission. |
|
| C92.01 | Acute myeloid leukemia, in remission | Use when AML is in remission after treatment. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for acute myeloid leukemia
Essential facts and insights about Acute Myeloid Leukemia
Primary ICD-10-CM Codes for acute myeloid leukemia
Decision Criteria
clinical Criteria
- Presence of >20% blasts in bone marrow or peripheral blood.
Applicable To
- Newly diagnosed AML
- Relapsed AML
Clinical Validation Requirements
- Blast count >20% in peripheral blood or bone marrow
- No evidence of remission
Code-Specific Risks
- Incorrectly coding remission status can lead to compliance issues.
Coding Notes
- Ensure documentation specifies the remission status clearly.
C92.01 - Acute myeloid leukemia, in remission
Use when AML is in remission after treatment.
Applicable To
- AML after successful chemotherapy
- AML post-transplant
Excludes
- Active AML (C92.00)
- AML in relapse (C92.02)
Clinical Validation Requirements
- Morphologic remission with <5% blasts
- No extramedullary disease
Coding Notes
Document remission status with supporting lab results.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Myelodysplastic syndromes
D46.-Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Acute Myeloid Leukemia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C92.00.
Impact
Clinical: Affects treatment decisions., Regulatory: May lead to coding audits., Financial: Potential for denied claims.
Mitigation Strategy
Ensure genetic testing results are documented., Include in all relevant coding.
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Misclassification may result in audits., Data Quality: Affects clinical data accuracy and patient care.
Mitigation Strategy
Verify remission status with lab results before coding.
Impact
Incorrect remission status can trigger audits.
Mitigation Strategy
Ensure accurate documentation of remission status.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Acute Myeloid Leukemia, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Acute Myeloid Leukemia
Use these documentation templates to ensure complete and accurate documentation for Acute Myeloid Leukemia. These templates include all required elements for proper coding and billing.
AML diagnosis and treatment
Specialty: OncologyRequired Elements
- Blast percentage
- Genetic profile
- Remission status
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Acute Myeloid Leukemia? Ask your questions below.